The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Seems to me there's a tremendous incentive for somebody to develop a molecule that can directly target SHBG, besides Oxandrolone and Anavar, right? If one could just drop SHBG just the tiniest bit, it seems like one could adjust the free T in a way that would be great. I don't know why that molecule's so hard to target, but somebody ought to do it.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.